UMIN ID: UMIN000001115
Registered date:09/04/2008
a phase II trial of amrubicin and carboplatin for patients with extensive stage small cell lung cancer
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | small cell lung cancer |
| Date of first enrollment | 2008/03/01 |
| Target sample size | 35 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | amurubicin+carboplatin |
Outcome(s)
| Primary Outcome | response rate |
|---|---|
| Secondary Outcome | progression free survival, overall survival, toxicity |
Key inclusion & exclusion criteria
| Age minimum | Not applicable |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1. severe cardiac effusion 2. severe supra vena cava syndrome 3. severe complication (angina pectoris, myocardial infarction, heart failure, diabetes, hypertension, infection, interstitial pneumonia) 4. active other cancer 5. pregnancy women 6. need radiotherapy for brain metastasis 7. limited stage small cell lung cancer |
Related Information
| Primary Sponsor | Nagasaki Thoracic Oncology Group |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Nagasaki Thoracic Oncology Group |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Minoru Fukuda |
| Address | 6-39 Shinchi-machi, Nagasaki 850-8555, Japan Japan |
| Telephone | 090-822-3251 |
| mifukuda258@nifty.com | |
| Affiliation | Nagasaki Municipal Hospital Internal Medicine |
| scientific contact | |
| Name | Minoru Fukuda |
| Address | 6-39 Shinchi-machi, Nagasaki 850-8555, Japan Japan |
| Telephone | 095-822-3251 |
| Affiliation | Nagasaki Thoracic Oncology Group Nagasaki Municipal Hospital |